Literature DB >> 11053379

Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide.

Y Hu1, J A Mangan, J Dhillon, K M Sole, D A Mitchison, P D Butcher, A R Coates.   

Abstract

Mycobacterium tuberculosis can persist in an altered physiological state for many years after initial infection, and it may reactivate to cause active disease. An analogous persistent state, possibly consisting of several different subpopulations of bacteria, may arise during chemotherapy; this state is thought to be responsible for the prolonged period required for effective chemotherapy. Using two models of drug-induced persistence, we show that both microaerophilic stationary-phase M. tuberculosis treated with a high dose of rifampin in vitro and pyrazinamide-induced persistent bacteria in mice are nonculturable yet still contain 16S rRNA and mRNA transcripts. Also, the in vitro persistent, plate culture-negative bacteria incorporate radioactive uridine into their RNA in the presence of rifampin and can rapidly up-regulate gene transcription after the replacement of the drug with fresh medium and in response to heat shock. Our results show that persistent M. tuberculosis has transcriptional activity. This finding provides a molecular basis for the rational design of drugs targeted at persistent bacteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053379      PMCID: PMC94781          DOI: 10.1128/JB.182.22.6358-6365.2000

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

1.  The death and resurrection of tuberculosis.

Authors:  B R Bloom; J D McKinney
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

2.  The mystery of the mycobacterial 'persistor'.

Authors:  J M Grange
Journal:  Tuber Lung Dis       Date:  1992-10

Review 3.  Mycobacterial dormancy.

Authors:  P R Gangadharam
Journal:  Tuber Lung Dis       Date:  1995-12

4.  Determination of Mycobacterium leprae viability by polymerase chain reaction amplification of 71-kDa heat-shock protein mRNA.

Authors:  B K Patel; D K Banerjee; P D Butcher
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

5.  Effect of stress treatments on the detection of Listeria monocytogenes and enterotoxigenic Escherichia coli by the polymerase chain reaction.

Authors:  C I Masters; J A Shallcross; B M Mackey
Journal:  J Appl Bacteriol       Date:  1994-07

6.  Identification of a central regulator of stationary-phase gene expression in Escherichia coli.

Authors:  R Lange; R Hengge-Aronis
Journal:  Mol Microbiol       Date:  1991-01       Impact factor: 3.501

7.  Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

Authors:  L G Wayne; H A Sramek
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis.

Authors:  D de Wit; M Wootton; J Dhillon; D A Mitchison
Journal:  Tuber Lung Dis       Date:  1995-12

9.  Assessment of mycobacterial viability by RNA amplification.

Authors:  G M van der Vliet; P Schepers; R A Schukkink; B van Gemen; P R Klatser
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Genomic organization of the mycobacterial sigma gene cluster.

Authors:  L Doukhan; M Predich; G Nair; O Dussurget; I Mandic-Mulec; S T Cole; D R Smith; I Smith
Journal:  Gene       Date:  1995-11-07       Impact factor: 3.688

View more
  62 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 2.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

3.  Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

Authors:  Yanmin Hu; Anthony R M Coates; Denis A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Sigma factor F does not prevent rifampin inhibition of RNA polymerase or cause rifampin tolerance in Mycobacterium tuberculosis.

Authors:  Ruben C Hartkoorn; Claudia Sala; Sophie J Magnet; Jeffrey M Chen; Florence Pojer; Stewart T Cole
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

5.  Activity of drug combinations against dormant Mycobacterium tuberculosis.

Authors:  Perla Filippini; Elisabetta Iona; Giovanni Piccaro; Pascale Peyron; Olivier Neyrolles; Lanfranco Fattorini
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

6.  New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells.

Authors:  Elena Salina; Olga Ryabova; Arseny Kaprelyants; Vadim Makarov
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

7.  Contradictory results with high-dosage rifamycin in mice and humans.

Authors:  A R M Coates; Yanmin Hu; A Jindani; D A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  2013-02       Impact factor: 5.191

8.  Reply to "Contradictory results with high-dosage rifamycin in mice and humans".

Authors:  Eric L Nuermberger; Ian M Rosenthal; Rokeya Tasneen; Charles A Peloquin; Khisimuzi E Mdluli; Petros C Karakousis; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2013-02       Impact factor: 5.191

9.  Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

Authors:  Nicholas D Walter; Gregory M Dolganov; Benjamin J Garcia; William Worodria; Alfred Andama; Emmanuel Musisi; Irene Ayakaka; Tran T Van; Martin I Voskuil; Bouke C de Jong; Rebecca M Davidson; Tasha E Fingerlin; Katerina Kechris; Claire Palmer; Payam Nahid; Charles L Daley; Mark Geraci; Laurence Huang; Adithya Cattamanchi; Michael Strong; Gary K Schoolnik; John Lucian Davis
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

10.  Mesosome formation is accompanied by hydrogen peroxide accumulation in bacteria during the rifampicin effect.

Authors:  Xin Li; Hanqing Q Feng; Xinyue Y Pang; Hongyu Y Li
Journal:  Mol Cell Biochem       Date:  2007-12-28       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.